RGPX

Regenerex Pharma's auditor, dbbmckennon, resigned effective August 31, 2026, after serving since…

The auditor resignation is a material adverse signal for a micro-cap company already flagged with going-concern doubt. Traders should expect heightened volatility and potential selling pressure as…

Regenerex Pharma filed an 8-K disclosing that its Quarterly Reports on Form 10-Q for the quarters…

The delinquent quarterly filings and failure to file Form 12b-25 are red flags for SEC compliance. Monitor for any SEC enforcement action, trading suspension, or going-concern language in the…

Regenerex Pharma filed an 8-K disclosing that it has commenced litigation against its former CFO…

This filing reveals a severe internal control failure and potential fraud at the CFO level, directly causing a late 10-K filing. For a micro-cap OTC stock, this creates material going-concern and…

Regenerex Pharma terminated its CFO Kenneth Perry for cause following a committee review of…

Monitor for follow-up filings such as an NT 10-K/Q or restatement (4.02), which would confirm material weaknesses. The interim CFO's 90-day term suggests urgency; watch for permanent CFO appointment…